chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information was received from a registered nurse concerning a 12 month old male, with an unspecified medical history, who on 24-APR-2007 was vaccinated with a dose of ProQuad (lot number 656170/1400F). It was reported that on 29-APR-2007 the patient experienced a chicken pox like rash in the diaper area, five days after receiving the vaccination. Unspecified medical attention was sought. The patient's status was unknown. No laboratory tests were performed. No product quality complaint was involved. Additional information has been requested.  10/06/2007 This is in follow-up to report(s) previously submitted on 7/6/2007. Initial and follow-up information was received from a registered nurse concerning a 16 month old male, with no pertinent medical history, who on the morning of 24-APR-2007 was vaccinated subcutaneously into the left thigh with a dose of PROQUAD (Oka/Merck upgrade process) (Lot # 656170/1400F). Concomitant therapy included IM TRIPEDIA (Lot # 1813AB), administered into the right thigh IM, ACTHIB (Lot # UE868AA), administered into the right thigh IM, and PREVNAR (Lot # B08674H), administered into the left thigh IM. It was reported that on 29-APR-2007, five days after receiving the vaccination, the patient experienced chickenpox-like "rash" lesions in the diaper area and a low-grade temperature. Unspecified medical attention was sought. The lesions continued and were present for about ten days. The patient recovered. No product quality complaint was involved. Additional information is not expected.
This spontaneous report was received from a pharmacist refers to a 29 year old male patient. On an unknown date, the 29 year old male patient was vaccinated with ZOSTAVAX (dose, route and frequency were not reported) Inappropriate schedule of vaccine administered). No adverse effects reported. No further information provided. Additional information has been requested.
Fever over 101 for 3 days. Rash developed on stomach on 11/21/2015.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information about concurrent medical conditions and medical history was not reported. On 02-JUL-2014, the patient was vaccinated with VARIVAX (merck) (dose and lot #: unknown, subcutaneously) which were given to the patient in error. No adverse effects were known a the time of the report. Additional information has been requested.
After receiving the Meningococcal A,C,W,Y vaccine in their upper left arms, both of my children went into distress and passed out. Their temperature spiked, extreme sweating ensued, and cold clammy like conditions were evident. Their blood pressure, heart rate, and pulse dropped to half the normal rate. Cold compresses were given and all vitals were monitored in the doctors office for 90 minutes.
This case was reported by a healthcare professional and described the occurrence of enlarged liver in a female subject (the aunt of the reporter) aged between 50 and 59 years old who was vaccinated with HEPATITIS B, manufacturer unspecified.  Concurrent medications included Thyroid replacement.  In 2004 the subject received unspecified dose of HEPATITIS B (unknown).  At an unspecified time after vaccination with HEPATITIS B, the subject complained that she was not feeling well or not feeling right (unspecified).  She was awakening with horrible dreams and she was distressed.  It was observed that the subject was confused.  She was in the bathroom saying things that made no sense and stumbling.  This was considered to be a systemic reaction.  A friend took her to the doctor and the doctor sent her to the hospital.  The hospital did a work-up.  The subject failed the neuro exams and she was hospitalized.  The events were also considered to be life threatening and clinically significant (or requiring intervention).  The subject died in the hospital an unknown amount of time later.  Initially in the hospital, the subject was thought to have Lyme disease or an inflammatory reaction, possibly an allergic reaction.  An autopsy revealed an enlarged liver and brain swelling.  Specific events of not feeling well or not feeling right, awakened with horrible nightmares and distress were said to have resolved and were considered probably related to vaccination with HEPATITIS B.  This case, A0738694A, is linked to two other cases from the same reporter.  The master case is A0738675A.  The other linked case is A0738681A.  Cases A0738675A and A0738681A are sibling cases.
Dizziness, Nausea.  Pt c/o dizziness a few mins after injection. No respiratory distress.  A&O x 4.  Water given VSS.  BP 101/58 HR 64, RR 18 -- > 110/80,60,18 Pt stable and released from vaccination site.
3/22/03 client had malaise post vaccine on 3/18/03, 3/23/03- client improved, 3/30/03- felt like comming down with cold,temp 100.F,  3/31/03-improvement noted in AM-later progressively got worse with increased fatigue, aches, temp 4/1/03-client is a registered nurse and felt intermittence pain (L) side of neck and back under (L) scapula- heard odd heart sound, temp 100.F- aches, SOA, fatigue- called place of work and was told to come in.
The next morning I was sitting in my chair watching tv and my fit bit buzzed and my heart rate was 120. I was tired and fatigued and my heart rate stayed elevated for a week and I became dizzy and my heart rate kept spiking and I had a lot of skipped beats and palpitations. I went to doctor.
patient said she passed out at 430 am in the morning the day after the vaccination. She suffered black and blue eyes, sore muscle and headache from the fall.
Broke out in hives/rash which continued to spread from face down my body,. Thick red swollen layer.  Receive injection of steroids and 7 day course of  oral steroids. Told to continue using Benadryl and Allegra. Another type of rash formed which resulted in me going to a dermatologist they next day. Stated they believe vaccine triggered a Shingles flare up and prescribed 7 day course of ValACYclovir 1 gr 3 x day.  Was uncertain of what the third rash I have is.  Face rash is improving but other two rashes are continuing to spread and are extremely  painful and itch.
SWELLING AND PAIN OVER THE LEFT DELTOID AREA FOLLOWED BY INTENSE ITCHING AND DEVELOPMENT OF PAPULAR ERUPTIONS WITHIN AN AREA OF 8 CM AROUND THE INJECTION SITES DIAGNOSIS; CELLULITIS DELTOID AREA.
Rash, rash has gotten progressively worse every day; Broke out in hives; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Broke out in hives) and RASH (Rash, rash has gotten progressively worse every day) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced RASH (Rash, rash has gotten progressively worse every day). In March 2021, the patient experienced URTICARIA (Broke out in hives). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Broke out in hives) and RASH (Rash, rash has gotten progressively worse every day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  The patient reported that about a month after receiving first dose of vaccine, the patient broke out in hives. The patient went to her HCP and was prescribed prednisone. However, the patient did not take prednisone, and alternatively took fexofenadine (Allegra). The patient stated that a month after receiving the first dose on 04-Mar-2021, a rash appeared and the rash had gotten progressively worse every day. The patient was asking if she could receive the second dose of the vaccination after the 28th day.
A week after getting the vaccine. I had a small eczema spot that got big and flared up. I put steroid cream and it did not respond well the cream, I did stop doing that.
Onset approx. 7 days; after vaccination: cardiac arrhythmia: PVC's with bigeminy and trigeminy - not resolving after 8 months.
This spontaneous report has been received from a medical assistant, referring to a patient of unknown age and gender. On 14-JUL-2017, the patient was vaccinated with an improperly storage dose of PNEUMOVAX 23 lot number m042324 with expiration date on 10-JUN-2018; lot number reported as "m044564" with expiration date on 22-OCT-2018 or lot number n001007 with expiration date on 09-SEP-2018 for prophylaxis. No adverse effects were reported. The doses of PNEUMOVAX 23 were exposed to a temperature of 47 Fahrenheit degrees (F) to 77 F for time frame of 1 hour 20 minutes. There were no previous temperature excursions. Digital data logger was involved. No symptoms reported. This is one of several reports received from the same source. Sender's Comments: US-009507513-1708USA002800.
first dose JAN-2022, not yet received second; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in January 2022).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 22-SEP-2022 Reporter's Comments: The reporters were a medical assistant and a physician. The patient had not yet received her second dose of Shingrix. The health care professional asked how to proceed with vaccination. The reporter did not provide the lot number and expiration date of Shingrix first dose vaccine. The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The case US2022136497 was identified as duplicate of case US2022136494. The case US2022136497 would be deleted and all future correspondence would be added in the present case US2022136494 which stands as case of record.
dizziness; lump in her throat; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) and SENSATION OF FOREIGN BODY (lump in her throat) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness) and SENSATION OF FOREIGN BODY (lump in her throat). On 13-Mar-2021, SENSATION OF FOREIGN BODY (lump in her throat) had resolved. At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included  Zyrtec
Received Expired Booster Vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Booster Vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Booster Vaccine). On 17-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Booster Vaccine) had resolved.
slight pain with the first shot but that gently faded but was still noticeable.  After the second shot I had a decent amount of pain in my shoulder that progressively became worse with loss of strength and loss of motion.  On the morning of 05/11/21 the pain was so bad it woke me from my sleep and scared me so much I have decided to call my orthopedic.  My first orthopedic appt is on 05/13/21.
Patient presented to clinic on 8/7/17 reporting she had be given the MMR vaccine on 7/27/17 and notes becoming febrile on 8/2/17 (tmax 103). She notes the fever continued with muscle pain to fluctuate over 5 days with onset of throat pain and swollen glands starting 8/6/17. Today, a rapid culture has been done and sent out; pending results. Patient instructed to increase fluids, rest, and use of ADVIL/TYLENOL as needed.
At 6 months, well child check up 11/12/04: Baby received DTP #3 HIB#3 Pre#3, Fluzone#1. Within two minutes, patient covered with hives from head to toe. No anaphylaxis. No respiratory distress. Alert and playful. Received 2.75 Benadryl po within 20 min, hives faded. Babe sent home to follow up with allergy.
swelling and itching at site--to be expected. By 8 pm, I had body aches, a headache and a low grade fever, fatigue, some chills but able to sleep.  It is not 48 hours since I got the booster and I still  have these symptoms improved by 60%. I am taking off from work tomorrow and will set up a video appointment if I am not greatly improved.  On the second shot, the same symptoms but not as intense.
Patient received first dose of the moderna covid vaccine.  He was fine receiving the vaccine but about 5 minutes later did not feel well and fainted.  By the time I got out there he had come to but was pale, clammy and had swollen lower lip.  After about  5 minutes and a bottle of water he regained his color and felt ok enough to leave on his own.  Paramedics arrived but did not treat patient.
1/16/19 Extreme fatigue, light headed, sore throat. Strep test, mono test, CBC & sick appointment with Dr., Pediatrician Platelet count 7,000 & very low WBC 1/17/19 CBC PLT 8,000 & very low WBC from 8:00 am appt. Dr Admitted to hospital under Dr., Hematologist at 4:00 pm At 6:00 pm CBC drawn results were PLT 10,000 & low WBC Diagnosed ITP resulting from MMR II vaccination 1/18/19 CBC drawn 6:00 am PLT 18,000 & WBC 3.9 discharged from hospital. No physical activities 1/21/19 CBC PLT 140,000 & WBC 4.61 Patient's symptoms from Jan. through May range from extreme tiredness, low energy & having a hard time focusing in school. He has not been able to participate in physical activities if his PLT are below 50,000 due to concern of internal bleeding. He plays Club Soccer at a high level year round along with High School soccer with the goal of being recruited & scholarship to play in college. He has to go weekly for bloodwork to see if his PLT counts are high enough each week to play. He has had to take Prednisone to increase PLT counts so he can participate in Club championship/state/regional games multiple times to ensure high enough counts & be able to play! His numbers have continued fluctuating & dropping down to 13,000 requiring Promacta prescription medicine to force his bone marrow to increase PLT production. Zofran also needed to deal with nausea from Promacta. He has been told his ITP could last 6 months to 5 plus years until his body re-sets itself & stops attacking his own PLT. We have his liver/organs checked each month to ensure the Promacta does not damage his liver & cause future health issues. This MMR vaccination has changed our son's life dramatically now & well into his future!
ADVERSE REACTIONS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced adverse reactions. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse reactions was not reported. This report was non-serious.
PT WAS VACCINATED WITH 6 JABS FOR PRIMARY (NEW) SMALLPOX VACCINATION. NORMAL APPEARING TAKE ON DAY 7, ON DAY 8 HAD MUCH INCREASED ERYTHEMA (14 CM), INDURATION (3 CM), BLISTER TO 2.5 CM WITH DARK/UMBILICATED CENTRAL AREA.
Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up report (s) previously submitted on 5/12/2006. Information has been received from a registered nurse concerning an elementary school-aged child who on 30-JUL-1997 was vaccinated with a dose of VARIVAX (Merck). On 01-MAR-2006, the patient developed breakthrought chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
A few days after receiving the first injection, I developed a severe rash up and down BOTH arms.  I could not stop scratching.  I tried taking Benadryl, Allegra, topical Benedryl, Calamin Lotion, Anti-Itch Cream, Aloe Vera and ice.  Nothing worked to stop the itching.  I could not sleep as I would itch all night long.  Finally, I went to urgent care about a week later and was given a Steroid shot and prescribed Pretazone for 10 days.  It went away but now the itching is returning.  Since also receiving the shot, I have experienced extreme fatigue and tiredness and have to sleep on and off throughout the day.  It takes energy some days to just go up and down my stairs or walk the mailbox.
Pt reported to nurse at 6:30pm same day of vaccines (4 hrs after receiving) that she thought she was having reaction. Described as "tickle and tightness in throat", "difficulty breathing" & occasional expiratory wheezes. Pt later stated that she started feeling this 20 minutes after receiving vaccines but did not report it. Pt appeared in no apparent distress at any time. Dr. was notified and Benadryl 25mg by mouth was administered at 7:51pm and albuterol nebulizer treatment. At 9:56PM. pt reports feeling 100% better and is no longer complaining of any of reported symptoms.
Heavy vaginal bleeding with heaving clots since the first does was administered. Vaginal bleeding continues as of today, April 13,2021 at 2:36pm 2nd side effect was herpes outbreak on right eyelid, my primary care provider was notified.
pt began itching on Friday noc, & rash broke out the next morning;5NOV98 MD dx allergic rxn to flu shot;hydrocortosone inj & 2 creams;
Vaccine administered with redness, swelling, pain, likely early cellulitis in area of injection site. Onset day after vaccination and day before evaluation
About 15 to 20 minutes lips tingling; numbness; Immeduately after injection light headed, dizzy; nausea; This is a spontaneous report from a contactable other healthcare professional, the patient. A 46-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733), via an unspecified route of administration in left arm on 08Apr2021 at 10:00 (at the age of 46-years-old) as single dose for COVID-19 immunisation. Medical history included unspecified allergies. Concomitant medication included Fluticasone propionate (FLONASE); Montelukast sodium (SINGULAIR) ; cetirizine hydrochloride (ZYRTEC); Memantine hydrochloride (ALZANTINA); all from unknown dates and for unknown indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 08Apr2021 at 10:00, immediately after the injection, the patient felt light-headed, dizzy and nauseated. After 15 to 20 minutes of vaccination, the patient experienced tingling lips and numbness. The patient did not receive any treatment for the reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events light-headed, dizzy, nausea, tingling lips and numbness was not recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
3rd dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 58-year-old male patient who received Herpes zoster (Shingrix) (batch number FA95N, expiry date 28-JUL-2023) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date in 2018) and Shingrix (2nd dose received on an unknown date in 2018).   On 07-OCT-2022, the patient received the 3rd dose of Shingrix. On 07-OCT-2022, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: 3rd dose administered). The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 17-MAR-2023 A pharmacist informed that a patient had received a 3rd dose of Shingrix, which led to extra dose administered. Originally the patient had finished the scheme back in 2018. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up
Diarrhea; Stomachache; This is a spontaneous report received from the contactable reporter(s) (Physician) from the medical information team. The reporter is the patient.  A 59-year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Mar2021 13:00 (Lot number: EN6200) at the age of 59 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DIARRHOEA (non-serious) with onset 01Mar2021, outcome "unknown", described as "Diarrhea"; ABDOMINAL PAIN UPPER (non-serious) with onset 01Mar2021, outcome "unknown", described as "Stomachache". Therapeutic measures were not taken as a result of diarrhoea. Additional information: The first dose of the Pfizer-BioNTech Covid-19 vaccine, 20 minutes later she experienced diarrhea. She would like to know if this could be a non-typical allergic reaction that prevents her from getting the second dose of the vaccine. The clinical course was she had explosive diarrhea 20 minutes after getting her first dose, and a bad stomachache that lasted maybe 40 minutes to an hour and she just wanted to find out since it was so explosive if for the second dose would it be possible to have this reaction to it if this first is an allergic reaction, though not a typical reaction, and if it would prevent getting the second dose.  No follow-up attempts are possible. No further information is expected.